SCHEMBL4233647

SCHEMBL4233647

COc1cccc(-n2c(CCCNc3ncnc4c3ncn4C3CCCCO3)nc3ccsc3c2=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 1/20 0.45
▸ CYP1A2 P05177 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ KMT2A Q03164 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ CYP2C19 P33261 1/20 0.36
▸ AURKA O14965 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ YTHDC1 Q96MU7 1/20 0.35
▸ EPHB4 P54760 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ADORA2A P29274 1/20 0.35
▸ ADORA1 P30542 1/20 0.35
▸ CCNA2 P20248 1/20 0.34
▸ CDK2 P24941 1/20 0.34
▸ CDK5 Q00535 1/20 0.34
▸ CDK5R1 Q15078 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4237005 0.93 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4228491 0.91 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4227217 0.89 SMN1; SMN2 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4227286 0.88 NPC1 (0.46) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4237270 0.86 PIK3CD (0.49) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL1704298 0.84 NPC1 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL4229018 0.83 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL1704245 0.76 NPC1 (0.42) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL12471910 0.75 NPC1 (0.55) NPC1RAB9ASMN1; SMN2CYP1A2HPGD
SCHEMBL1703383 0.75 NPC1 (0.49) NPC1RAB9ASMN1; SMN2CYP1A2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 — — EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 — — WO disclosed
Send feedback